Crinetics Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	3,782	4,449	4,751	2,426	986	1,352
Market Cap Growth	25.77%	-6.36%	95.88%	146.02%	-27.09%	190.40%
Enterprise Value	2,539	3,470	3,449	1,919	654.6	1,022
Last Close Price	35.87	46.55	51.13	35.58	18.30	28.41
PS Ratio	209.32	578.10	4572.96	604.45	208.14	1254.39
PB Ratio	2.95	4.48	3.59	4.50	3.12	4.07
P/TBV Ratio	2.71	4.41	3.12	3.83	3.01	3.29
EV/Sales Ratio	140.50	450.84	3319.50	478.16	138.19	947.68
Debt / Equity Ratio	0.03	0.04	0.03	0.09	0.01	0.01
Net Debt / Equity Ratio	-0.97	-0.99	-0.98	-0.94	-1.05	-1.00
Net Debt / EBITDA Ratio	2.30	1.91	3.88	2.29	1.99	3.10
Net Debt / FCF Ratio	2.96	2.55	5.57	2.93	2.84	3.71
Asset Turnover	0.01	0.01	0.00	0.01	0.01	0.00
Inventory Turnover	0.50	1.06	-	-	-	-
Quick Ratio	18.25	12.09	22.69	12.71	12.06	20.86
Current Ratio	18.60	12.32	23.04	13.07	12.45	21.55
Return on Equity (ROE)	-43.68%	-40.17%	-32.02%	-50.16%	-50.57%	-42.98%
Return on Assets (ROA)	-43.20%	-40.37%	-32.74%	-45.08%	-47.75%	-40.30%
Return on Invested Capital (ROIC)	-633.59%	-670.64%	-498.46%	-572.90%	-1916.79%	-1536.19%
Return on Capital Employed (ROCE)	-46.03%	-42.78%	-34.47%	-48.61%	-50.91%	-42.40%
Buyback Yield / Dilution	-12.58%	-16.43%	-39.11%	-11.71%	-35.24%	-26.23%
Total Shareholder Return	-12.58%	-16.43%	-39.11%	-11.71%	-35.24%	-26.23%

SEC Filings: 10-K · 10-Q